Skip to content

Clinical trials

Terminated Depressive Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Status: Terminated Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20082
20092
20101
20111
20131
20151
20173
20182
20212
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University4
Limbix Health, Inc.2
National Institute of Mental Health (NIMH)2
VA Office of Research and Development2
Abbott Medical Devices1
Freeman-Sheldon Research Group, Inc.1
GlaxoSmithKline1
Icahn School of Medicine at Mount Sinai1
Jessica Harder1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder25
Major Depressive Disorder11
Mood Disorders4
Anxiety Disorders3
Bipolar Disorder3
Depressive Disorder, Treatment-Resistant2
Stress Disorders, Post-Traumatic2
Affective Disorders, Psychotic1
Alcoholism1
Arthrogryposis1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.